INTRODUCTION: The simultaneous interpretation of serum ferritin level and transferrin saturation has been used as a clinical guide to diagnose genetic hemochromatosis. The Hemochromatosis and Iron Overload Screening (HEIRS) Study screened 101,168 North American participants for serum ferritin level and transferrin saturation, and C282Y genotyping for the HFE gene. METHODS: Logistic regression involving a subsample of Caucasians (n=44,809) was used to predict individual probabilities of HFE C282Y homozygosity using serum ferritin and transferrin saturation values. Men (n=17,323) and women (n=27,486) were analyzed separately. Regression equations were evaluated using area under the curve from ROC analysis and variance explained by Nagelkerke's pseudo R-squared. An Android smartphone App and website application were developed to provide physicians with easy access to predicting C282Y homozygosity of the HFE gene. RESULTS: The logistic equation had an area under the ROC curve of 0.91 for men and 0.89 for women. The pseudo R-squared was 0.44 for men and 0.34 for women. An example analysis was a Caucasian man with a transferrin saturation of 50% and a ferritin level of 500 µg⁄L, who had a 1.3% (95% CI 1.1% to 8.8%) probability of being a C282Y homozygote. CONCLUSIONS: A large primary care-based sample of 44,809 participants contributed to the development of a new computer⁄smartphone tool that predicts the probability of being a C282Y homozygote of the HFE gene from serum ferritin and transferrin saturation values.
INTRODUCTION: The simultaneous interpretation of serum ferritin level and transferrin saturation has been used as a clinical guide to diagnose genetic hemochromatosis. The Hemochromatosis and Iron Overload Screening (HEIRS) Study screened 101,168 North American participants for serum ferritin level and transferrin saturation, and C282Y genotyping for the HFE gene. METHODS: Logistic regression involving a subsample of Caucasians (n=44,809) was used to predict individual probabilities of HFEC282Y homozygosity using serum ferritin and transferrin saturation values. Men (n=17,323) and women (n=27,486) were analyzed separately. Regression equations were evaluated using area under the curve from ROC analysis and variance explained by Nagelkerke's pseudo R-squared. An Android smartphone App and website application were developed to provide physicians with easy access to predicting C282Y homozygosity of the HFE gene. RESULTS: The logistic equation had an area under the ROC curve of 0.91 for men and 0.89 for women. The pseudo R-squared was 0.44 for men and 0.34 for women. An example analysis was a Caucasian man with a transferrin saturation of 50% and a ferritin level of 500 µg⁄L, who had a 1.3% (95% CI 1.1% to 8.8%) probability of being a C282Y homozygote. CONCLUSIONS: A large primary care-based sample of 44,809 participants contributed to the development of a new computer⁄smartphone tool that predicts the probability of being a C282Y homozygote of the HFE gene from serum ferritin and transferrin saturation values.
Authors: Paul C Adams; David M Reboussin; Cathie Leiendecker-Foster; Godfrey C Moses; Gordon D McLaren; Christine E McLaren; Fitzroy W Dawkins; Ishmael Kasvosve; Ron T Acton; James C Barton; Dan Zaccaro; Emily L Harris; Richard Press; Henry Chang; John H Eckfeldt Journal: Clin Chem Date: 2005-04-15 Impact factor: 8.327
Authors: Paul C Adams; Mark Speechley; James C Barton; Christine E McLaren; Gordon D McLaren; John H Eckfeldt Journal: Hepatology Date: 2012-04-18 Impact factor: 17.425
Authors: Christine E McLaren; James C Barton; Paul C Adams; Emily L Harris; Ronald T Acton; Nancy Press; David M Reboussin; Gordon D McLaren; Phyliss Sholinsky; Ann P Walker; Victor R Gordeuk; Catherine Leiendecker-Foster; Fitzroy W Dawkins; John H Eckfeldt; Beverly G Mellen; Mark Speechley; Elizabeth Thomson Journal: Am J Med Sci Date: 2003-02 Impact factor: 2.378
Authors: Paul C Adams; David M Reboussin; James C Barton; Christine E McLaren; John H Eckfeldt; Gordon D McLaren; Fitzroy W Dawkins; Ronald T Acton; Emily L Harris; Victor R Gordeuk; Catherine Leiendecker-Foster; Mark Speechley; Beverly M Snively; Joan L Holup; Elizabeth Thomson; Phyliss Sholinsky Journal: N Engl J Med Date: 2005-04-28 Impact factor: 91.245
Authors: Paul C Adams; David M Reboussin; Richard D Press; James C Barton; Ronald T Acton; Godfrey C Moses; Catherine Leiendecker-Foster; Gordon D McLaren; Fitzroy W Dawkins; Victor R Gordeuk; Laura Lovato; John H Eckfeldt Journal: Am J Med Date: 2007-11 Impact factor: 4.965
Authors: Mark A Hall; James C Barton; Paul C Adams; Christine E McLaren; Jacob A Reiss; Oswaldo Castro; Andrea Ruggiero; Ronald T Acton; Tara E Power; Thomas C Bent Journal: J Fam Pract Date: 2007-10 Impact factor: 0.493